Baxdrostat

Overview

Baxdrostat is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4113975).

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Baxdrostat expires 4 Feb 2033 and exclusivity 15 May 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

N-[(8R)-4-(1-methyl-2-oxo-3,4-dihydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl]propanamide

Canonical SMILES

CCC(=O)N[C@@H]1CCCC2=C1C=NC=C2C3=CC4=C(C=C3)N(C(=O)CC4)C

InChIKey

VDEUDSRUMNAXJG-LJQANCHMSA-N